Lv2
190 积分 2023-08-27 加入
Ezh2, endothelin-1, and cd34 as biomarkers of aggressive cervical squamous cell carcinoma: an immunohistochemical study
3个月前
已关闭
EZH2 inhibitor Tazemetostat synergizes with JQ-1 in esophageal cancer by inhibiting c-Myc signaling pathway
7个月前
已完结
High-Level Expression of RIPK4 and EZH2 Contributes to Lymph Node Metastasis and Predicts Favorable Prognosis in Patients With Cervical Cancer
7个月前
已关闭
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy
10个月前
已完结
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy
10个月前
已关闭
Non-Apoptotic Cell Death Programs in Cervical Cancer with an Emphasis on Ferroptosis
10个月前
已完结
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer
10个月前
已完结
288MO InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer
10个月前
已完结
LBA44 Camrelizumab plus famitinib versus camrelizumab alone and investigator’s choice of chemotherapy in women with recurrent or metastatic cervical cancer
10个月前
已完结
Incorporation of triapine (T) with cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial
10个月前
已完结
皖公网安备34019202002308
